News | 31 August 2026
Genentech to invest $750 million in new injectable manufacturing facility in Oregon
Roche unit plans end-to-end fill-finish site in Hillsboro to support portfolio and pipeline injectables
Roche unit plans end-to-end fill-finish site in Hillsboro to support portfolio and pipeline injectables
Lannett company commercialises first product from its inhalation pipeline in two strengths
The broader financing package, including a concurrent private placement by Skye, will deliver approximately $125 million in gross proceeds to the combined company
The detector enables high-speed four-dimensional scanning transmission electron microscopy
The launch of Kerr in India comes during the brand’s landmark 135th anniversary year, underscoring its long-standing legacy of quality, clinical excellence and innovation
13 workshops, two days and one goal: Neonatologists, nurses and global experts come together in Bengaluru to strengthen skills, share evidence and advance neonatal intensive care
Regulatory action follows findings related to unauthorised labelling, recall compliance, drug storage and discrepancies in stock records
The new facility will more than triple Evonik’s existing manufacturing capacity for advanced pharmaceutical products in Vancouver
Lilly said Mounjaro is the first and only GIP and GLP-1 receptor agonist shown to reduce the risk of major adverse cardiovascular events in this population
The proposed venture will create a locally based manufacturing facility for the manufacture, processing, testing, packaging, marketing and supply of male condoms and related products
.png)
The system also features the Aegis Detector System, engineered to enhance image clarity and low-contrast detectability while supporting low-dose imaging protocols
Women’s longevity is the top wellness trend of the year
The programme will focus on research-to-policy translation, implementation science, real-world evidence, community participation, research integrity and AI in health research
£375,000 Innovate UK-backed partnership to use data analytics and predictive modelling to improve formulation, product development and decision-making
Board approves Mexico and Canada subsidiaries as the company advances international expansion and integrates its Rs. 91 crore Apnar Pharma acquisition
The company currently holds 96% of Bharat Serums and Vaccines directly, while the remaining 4% is held through its wholly owned subsidiary, Appian Properties
Field data indicates that joint and body pain and other musculoskeletal conditions account for 22% of commonly observed conditions, followed by respiratory tract infections at 18% and common cold and flu at 15%
The company plans to use proceeds from the fresh issue primarily for repayment or pre-payment of borrowings, capital expenditure at its Hyderabad facilities
Subscribe To Our Newsletter & Stay Updated
